BioCentury
ARTICLE | Company News

Competitive Technologies Inc., Genzyme deal

January 2, 2006 8:00 AM UTC

CTT granted GENZ a license to U.S. Patent No. 4,940,658 covering homocysteine tests. CTT will receive an upfront payment and is eligible for royalties. Homocysteine is a marker for cardiovascular and ...